2019
Anhedonia as a Key Clinical Feature in the Maintenance and Treatment of Opioid Use Disorder
Kiluk BD, Yip SW, DeVito EE, Carroll KM, Sofuoglu M. Anhedonia as a Key Clinical Feature in the Maintenance and Treatment of Opioid Use Disorder. Clinical Psychological Science 2019, 7: 1190-1206. PMID: 32042509, PMCID: PMC7009780, DOI: 10.1177/2167702619855659.Peer-Reviewed Original ResearchOpioid use disorderClinical featuresUse disordersHigher anhedonia scoresKey clinical featuresRate of participantsAnhedonia scoresOpioid-dependent sampleOpioid cravingOpioid useTreatment adherenceHealthy controlsSignificant anhedoniaPharmacological interventionsAssessment of anhedoniaMajority of studiesPotential targetAnhedoniaTreatmentTime courseDisordersSignificant knowledge gapsScoresPotential implicationsCritical need
2015
Chapter 16 Perspectives on neurocognitive rehabilitation as an adjunct treatment for addictive disorders From cognitive improvement to relapse prevention
Rezapour T, DeVito EE, Sofuoglu M, Ekhtiari H. Chapter 16 Perspectives on neurocognitive rehabilitation as an adjunct treatment for addictive disorders From cognitive improvement to relapse prevention. Progress In Brain Research 2015, 224: 345-369. PMID: 26822366, DOI: 10.1016/bs.pbr.2015.07.022.Peer-Reviewed Original ResearchConceptsNeurocognitive rehabilitationNeurocognitive deficitsCognitive neuroscienceDrug addictionAddiction treatmentLong-term abstinenceExecutive controlCognitive rehabilitationSustained attentionFlexible delivery methodsCognitive improvementAddictive behaviorsCognitive functionAddiction medicineNeurocognitive functionAddictive disordersEarly abstinencePsychosocial therapySustained abstinenceAbstinenceAddictionNeuroscienceDeficitsTreatment adherenceDrug use